Trial Details

TERMINATED
Basic Information
Clinical ID c1293
Identifier NCT00254618
Trial Title A Study of Asacol Absorption, Metabolism and Excretion in Children and Adolescents With Ulcerative Colitis.
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Ulcerative Colitis
Interventions DRUG: mesalamine|DRUG: mesalamine|DRUG: mesalamine
Participant Information
Sponsor Warner Chilcott
City Birmingham
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement CHILD
Study Design
Study Type INTERVENTIONAL
Phase PHASE1
Time Information
Start Date 2025-10-05
Primary Completion Date 2025-06-08
Completion Date 2025-06-08